Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transtion by registering with Grants.gov and NIH eRA Commons now. |
RFI: Preclinical Development Facility for Medical Countermeasures Against Chemical Threats
Release Date: September 2, 2005
Announcement Number: NOT-NS-05-012
Funding Contact: Helene Braun
Program Area: Office of Translational Research, Contracts Management Branch
Brief Description:
The National Institute of Neurological Disorders and Stroke (NINDS) is considering issuing a contract for preclinical studies
of new or improved pharmaceutical preparations to be used as medical countermeasures against chemical agents that could be
used in a terrorist attack. As a first step, the Institute is attempting to identify expert sources to conduct safety, pharmacokinetic/biodistribution,
and developmental chemistry studies with candidate drugs.
Choose an option to view additional funding announcements |
New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives |